4%阿尔蒂卡因在4岁以下儿童的不良事件:一项观察性研究
H Ananthu1, Ashwin P Rao2, Ashwin Kamath3
1Department of Pediatric and Preventive Dentistry, NITTE (Deemed to be University), AB Shetty Memorial Institute of Dental Sciences (ABSMIDS), Mangaluru, India.
International journal of clinical pediatric dentistry
|December 2, 2025
概括
这项研究在4岁以下的儿童中没有发现与4%的阿尔蒂卡因与上腺素直接相关的不良事件. 然而,建议谨慎使用,因为阿尔蒂卡因通常不推用于这个年龄组.
科学领域:
- 儿科牙科 儿科牙科
- 药理学 药理学是指药理学的学科.
- 麻醉学 麻醉学
背景情况:
- 关于4岁以下儿童使用阿尔蒂卡因的数据有限.
- 这项研究涉及4%的阿尔蒂卡因与1:1,000,000的上腺素在这个年龄组内用于上皮骨注射的安全性.
研究的目的:
- 观察4岁以下儿童中与4%的阿提卡因和上腺素相关的不良事件 (AE) 的类型和严重程度.
- 评估任何观察到的AE的因果关系和可预防性.
主要方法:
- 一项观察性研究涉及大约30名4岁以下的儿童,需要进行骨上注射.
- 使用Kalenderian方法记录了AE,并使用WHO-UMC尺度评估了因果关系.
- 使用修改的舒莫克和桑顿规模评估了可预防性.
主要成果:
- 在注射后60分钟内,三名儿童 (23.1%) 在复杂的手术中经历了暂时的轻度疼痛.
- 在因果关系方面,疼痛被归类为"不太可能"和"可能可以预防".
- 在观察到的时间范围内,没有其他副作用与麻醉剂直接相关.
结论:
- 该研究没有发现与4%的阿尔蒂卡因与4岁以下儿童的上腺素相关的直接不良事件.
- 尽管有这些发现,但目前还不建议在4岁以下的儿童中使用阿尔蒂卡因.
相关概念视频
Local Anesthetics: Adverse Effects
739
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
739
Parenteral Anesthetics: Overview
546
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
546
Drug Dosing: Infants and Children
234
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
234
Local Anesthetics: Clinical Application as Epidural Anesthesia
672
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
672
Depolarizing Blockers: Pharmocokinetics
553
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
553
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
231
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
231


